Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)
By Jorgen Vestbo, W. Anderson, H. Coxson, C. Crim, F. Dawber, L. Edwards, G. Hagan, K. Knobil, David A. Lomas, W. Macnee and 3 more. European Respiratory Journal, 2008
787 citations recorded by the source corpus.
Subfields: Physiology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/3efd8c0d7f0560b6362e086f84363921fda1e5b9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Physiology
In Pulmonary and Respiratory Medicine
Citations in the corpus
- The present and future of deep learning in radiology. (2019, background): “The dataset consisted of 7,983 COPD Gene participants for training and 1000 COPDGene [77] and 1672 ECLIPSE (Evaluations of COPD Longitudinally to Identify Predictive Surrogate Endpoints) [78] participants for testing.”
- Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype (2012, methodology): “gov identifier NCT00292552; GSK study code SCO104960) have been published previously [17].”
- Characterisation of COPD heterogeneity in the ECLIPSE cohort (2010, methodology): “Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) is a large observational study of COPD patients and controls conducted at 46 centres in 12 countries aimed at defining COPD phenotypes and identifying biomarkers and/or genetic parameters that help to predict dise”